Downregulation of inhibitor of growth 3 is correlated with tumorigenesis and progression of hepatocellular carcinoma

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 47-52

  Lu, Meiling ^a,b   Chen, Fei ^b   Wang, Qinwan ^a,b   Wang, Kesheng ^a,b   Pan, Qiuhui ^a   Zhang, Xin ^b  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Cell migration; Cell proliferation; Hepatocellular carcinoma; ING3; Tumorigenesis

Indexed keywords

GROWTH INHIBITOR; INHIBITOR OF GROWTH 3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

EID: 84861312774     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.685     Document Type: Article

References (28)

1. He GH, Helbing CC, Wagner MJ, Sensen CW and Riabowol K: Phylogenetic analysis of the ING family of PHD finger proteins. Mol Biol Evol 22: 104-116, 2005.
2. Toyama T, Iwase H, Watson P, et al: Suppression of ING1 expression in sporadic breast cancer. Oncogene 18: 5187-5193, 1999.
3. Nagashima M, Shiseki M, Miura K, et al: DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci USA 98: 9671-9676, 2001.
4. Shimada Y, Saito A, Suzuki M, Takahashi E and Horie M: Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor. Cytogenet Cell Genet 83: 232-235, 1998.
5. Nagashima M, Shiseki M, Pedeux RM, et al: A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 22: 343-350, 2003.
6. Shiseki M, Nagashima M, Pedeux RM, et al: p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 63: 2373-2378, 2003.
7. Zhang X, Xu LS, Wang ZQ, et al: ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett 570: 7-12, 2004.
8. Coles AH and Jones SN: The ING gene family in the regulation of cell growth and tumorigenesis. J Cell Physiol 218: 45-57, 2009.
9. Gong W, Suzuki K, Russell M and Riabowol K: Function of the ING family of PHD proteins in cancer. Int J Biochem Cell Biol 37: 1054-1065, 2005.
10. Russell M, Berardi P, Gong W and Riabowol K: Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res 312: 951-961, 2006.
11. Campos EI, Chin MY, Kuo WH and Li G: Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 61: 2597-2613, 2004.
12. Tokunaga E, Maehara Y, Oki E, et al: Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett 152: 15-22, 2000.
13. Oki E, Maehara Y, Tokunaga E, Kakeji Y and Sugimachi K: Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett 147: 157-162, 1999.
14. Hara Y, Zheng Z, Evans SC, et al: ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. Cancer Lett 192: 109-116, 2003.
15. Okano T, Gemma A, Hosoya Y, et al: Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncol Rep 15: 545-549, 2006.
16. Fang F, Luo LB, Tao YM, Wu F and Yang LY: Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 18: 409-416, 2009.
17. Lu F, Dai DL, Martinka M, Ho V and Li G: Nuclear ING2 expression is reduced in human cutaneous melanomas. Br J Cancer 95: 80-86, 2006.
18. Zhang HK, Pan K, Wang H, et al: Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett 261: 183-192, 2008.
19. Garkavtsev I, Kozin SV, Chernova O, et al: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328-332, 2004.
20. Kim S, Chin K, Gray JW and Bishop JM: A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 101: 16251-16256, 2004.
21. Gunduz M, Nagatsuka H, Demircan K, et al: Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356: 109-117, 2005.
22. Lu ML, Chen F, Wang QW, Han ZG and Zhang X: Study on expression of ING5 in hepatocellular carcinoma. Wei Chang Bing Xue Za Zhi Tou Gao Xu Zhi 15: 86-89, 2010.
23. Wang Y and Li G: ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells. J Biol Chem 281: 11887-11893, 2006.
24. Gunduz M, Beder LB, Gunduz E, et al: Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer. Cancer Sci 99: 531-538, 2008.
25. Wang Y, Dai DL, Martinka M and Li G: Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Clin Cancer Res 13: 4111-4116, 2007.
26. Ohgi T, Masaki T, Nakai S, et al: Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand J Gastroenterol 37: 1440-1448, 2002.
27. Zhu Z, Luo Z, Li Y, Ni C, Li H and Zhu M: Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 49: 504-512, 2009.
28. Chen G, Wang Y, Garate M, Zhou J and Li G: The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. Oncogene 29: 1498-1508, 2010.